Skip to main content
. 2019 Sep 18;3(3):bjgpopen19X101656. doi: 10.3399/bjgpopen19X101656

Table 3. Eligibility and achievement of individual prevention and screening actions.

Prevention and screening actionsa Eligibleb Achievedc
n % n % 95% CI
Screening
1. FBS or HbA1c monitoring (n = 145) 3 2.1 1 33.3 0.8 to 90.6
2. BP monitor (n = 153) 6 3.9 1 16.7 0.4 to 64.1
3. Cervical cancer screen (n = 90) 8 8.9 6 75 34.9 to 96.8
4. Breast cancer screen (n = 115) 16 13.9 12 75 47.6 to 92.7
5. BP screen (n = 153) 26 17.0 15 57.7 36.9 to 76.7
6. CRC screen (n = 154) 36 23.4 14 38.9 23.1 to 56.5
7. LDL measured (n = 153) 40 26.1 25 62.5 45.8 to 77.3
8. FBS or HbA1c screen (n = 154) 45 29.2 20 44.4 29.6 to 60.0
9. Smoking screen (n = 154) 65 42.2 24 36.9 25.3 to 49.8
10. Alcohol use screen (n = 154) 99 64.3 48 48.5 38.3 to 58.8
11. Physical activity screen (n = 154) 104 67.5 63 60.6 50.5 to 70.0
12. Nutrition screen (n = 154) 129 83.8 53 41.1 32.5 to 50.1
13. BMI screen (n = 154) 131 85.1 108 82.4 74.8 to 88.5
14. Waist circumference recorded (n = 154) 147 95.5 123 83.7 76.7 to 89.3
Treatment i nitiation or r eferral
15. Cholesterol treatment (n = 121) 2 1.7 2 100 15.8 to 100.0
16. Referral smoking cessation (n = 154) 22 14.3 5 22.7 7.8 to 45.4
17. Referral alcohol cessation (n = 154) 104 67.5 4 3.9 1.1 to 9.6
18. Referral nutrition (n = 154) 123 79.9 44 35.8 27.3 to 44.9
19. Referral physical activity (n = 153) 130 85.0 36 27.7 20.2 to 36.2
20. Referral weight control (n = 151) 132 87.4 58 43.9 35.3 to 52.8
Risk m odification
21. LDL improvement (n = 121) 18 14.9 11 61.1 35.8 to 82.7
22. Smoking cessation (n = 154) 22 14.3 8 36.4 17.2 to 59.3
23. Hypertension control (n = 153) 29 19.0 24 85.7 67.3 to 96.0
24. At risk alcohol improvement (n = 154) 79 51.3 32 60.4 46.0 to 73.4
25. Diet score improvement (n = 154) 123 79.9 54 62.1 51.0 to 72.3
26. Physical activity improvement (n = 153) 130 85.0 61 67 56.4 to 76.5
27. Overweight stabilisation (n = 151) 132 87.4 67 50.8 41.9 to 59.6

BMI = body mass index. BP = blood pressure. CI = confidence intervals. CRC = colorectal cancer. FBS = fasting blood sugar. HbA1c = haemoglobin A1C. LDL = low-density lipoprotein.

aComplete description of each item available from the authors on request. This column includes the number of participants for whom this CDPS action was assessable at follow-up. Action items intended for women were only assessed for female participants (n = 119). bIndicates the patients who were eligible to improve the action at baseline. cOf the patients who were eligible at baseline, indicates the patients who accomplished the action at follow-up.